This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Ozone
- DrugBank Accession Number
- DB12510
- Background
-
Ozone has been used in trials studying the treatment of Mild Asthma and Primary Apical Periodontite.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
-
Structure for Ozone (DB12510)
- Weight
-
Average: 47.997
Monoisotopic: 47.98474386 - Chemical Formula
- O3
- Synonyms
-
- ozono
Pharmacology
- Indication
-
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning models
with evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets. - Contraindications & Blackbox Warnings
-
Avoid life-threatening adverse drug eventsImprove clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support. - Pharmacodynamics
-
Not Available
- Mechanism of action
- Not Available
- Absorption
-
Not Available
- Volume of distribution
-
Not Available
- Protein binding
-
Not Available
- Metabolism
- Not Available
- Route of elimination
-
Not Available
- Half-life
-
Not Available
- Clearance
-
Not Available
- Adverse Effects
-
Improve decision support & research outcomesWith structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data. - Toxicity
-
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
-
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided byClassyfire
-
- Description
- This compound belongs to the class of inorganic compounds known as other non-metal oxides. These are inorganic compounds containing an oxygen atom of an oxidation state of -2, in which the heaviest atom bonded to the oxygen belongs to the class of 'other non-metals'.
- Kingdom
- Inorganic compounds
- Super Class
- Homogeneous non-metal compounds
- Class
- Other non-metal organides
- Sub Class
- 其他非金属氧化物s
- Direct Parent
- 其他非金属氧化物s
- Alternative Parents
- Inorganic oxides
- Substituents
- Inorganic oxide/其他非金属氧化物
- Molecular Framework
- Not Available
- External Descriptors
- reactive oxygen species, triatomic oxygen, elemental molecule (CHEBI:25812)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 66H7ZZK23N
- CAS number
- 10028-15-6
- InChI Key
- CBENFWSGALASAD-UHFFFAOYSA-N
- InChI
-
InChI=1S/O3/c1-3-2
- IUPAC Name
-
2lambda4-trioxida-1,2-diene
- SMILES
-
[O-][O+]=O
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
-
Phase Status Purpose Conditions Count 4 Completed Other Ocular Infection 1 4 Completed Treatment 研究必威国际app代用tiveness of a Corticosteroid, Single Dose and Three Doses of Ozone Injection in Shoulder Impingement Syndrome 1 4 Unknown Status Supportive Care Sepsis 1 4 Unknown Status Treatment Back pain 1 3 Not Yet Recruiting Treatment Coronavirus Disease 2019 (COVID‑19)/COVID-19 Pneumonia 1 3 Recruiting Treatment Osteoarthritis of the Knee 1 2 Active Not Recruiting Treatment Interstitial Cystitis, Chronic/Painful Bladder Syndrome (PBS) 1 2 Completed Treatment Impacted Third Molar Tooth 1 2 Completed Treatment Primary Apical Periodontite 1 2 Enrolling by Invitation Treatment Coronavirus Disease 2019 (COVID‑19) 1
Pharmacoeconomics
- Manufacturers
-
Not Available
- Packagers
-
Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
-
Property Value Source logP -0.21 ChemAxon pKa (Strongest Acidic) -1.3 ChemAxon Physiological Charge 0 ChemAxon Hydrogen Acceptor Count 3 ChemAxon Hydrogen Donor Count 0 ChemAxon Polar Surface Area 74.27 Å2 ChemAxon Rotatable Bond Count 0 ChemAxon Refractivity 4.24 m3·mol-1 ChemAxon Polarizability 2.31 Å3 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter No ChemAxon Veber's Rule No ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
-
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Drug created at October 20, 2016 22:40 / Updated at June 12, 2020 16:53